Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-07
1999-11-23
Mach, D. Margaret M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142292, 5142302, 5142245, 544 66, 544 32, 544101, 546 94, A61K 3140, A61K 3147, C07D215233, C07D22102
Patent
active
059901225
ABSTRACT:
The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a tricyclic amine radical, their salts, processes for their preparation and antibacterial compositions comprising these compounds.
REFERENCES:
patent: 4864023 (1989-09-01), Yokose
patent: 4988709 (1991-01-01), Ogata
patent: 5026856 (1991-06-01), Yatsunami
patent: 5312823 (1994-05-01), Petersen
patent: 5457104 (1995-10-01), Bartel
patent: 5578604 (1996-11-01), Himmler
patent: 5585491 (1996-12-01), Domagala
patent: 5631256 (1997-05-01), Demuth
patent: 5631266 (1997-05-01), Kim
patent: 5679675 (1997-10-01), Jaetsch
Derwert Abstract of JP 04-253 973, (Sep. 9, 1992).
Bartel Stephan
Bremm Klaus Dieter
Endermann Rainer
Jaetsch Thomas
Metzger Karl Georg
Bayer Aktiengesellschaft
M. Mach D. Margaret
LandOfFree
Quinolone- and naphthyridonecarboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolone- and naphthyridonecarboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolone- and naphthyridonecarboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222229